WO1996003496A1 - Culture medium promoting endocrine cell growth - Google Patents

Culture medium promoting endocrine cell growth Download PDF

Info

Publication number
WO1996003496A1
WO1996003496A1 PCT/FR1995/000961 FR9500961W WO9603496A1 WO 1996003496 A1 WO1996003496 A1 WO 1996003496A1 FR 9500961 W FR9500961 W FR 9500961W WO 9603496 A1 WO9603496 A1 WO 9603496A1
Authority
WO
WIPO (PCT)
Prior art keywords
cells
culture medium
culture
valine
cell
Prior art date
Application number
PCT/FR1995/000961
Other languages
French (fr)
Inventor
Marie Thérèse ZABOT
Jean Michel Zabot
Original Assignee
De Leobardy, Francis
DUGAST, Hervé
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by De Leobardy, Francis, DUGAST, Hervé filed Critical De Leobardy, Francis
Priority to AU30799/95A priority Critical patent/AU3079995A/en
Publication of WO1996003496A1 publication Critical patent/WO1996003496A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0613Cells from endocrine organs
    • C12N5/0617Thyroid and parathyroid glands
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/80Undefined extracts from animals
    • C12N2500/84Undefined extracts from animals from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/395Thyroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/11Coculture with; Conditioned medium produced by blood or immune system cells

Definitions

  • the present invention relates to a culture medium promoting cell growth of endocrine cells.
  • the ideal solution would therefore consist in replacing the only cells concerned.
  • To isolate these endocrine cells it is necessary to dissociate the tissue concerned then prepare, by filtration or suitable centrifugation, a cell suspension as enriched as possible in endocrine cells. It is the cell culture of this suspension which constitutes the second essential step of this purification.
  • This culture must be selective, in order to permanently conserve only the endocrine cells; it must be adapted to allow the conservation of the functional characteristics of these cells as well as their multiplication in vitro.
  • the present invention is given for the purpose of solving the problem before it by providing a new culture medium consisting of the association of nutrients and stimulants able to meet the dual requirements defined above.
  • the culture medium promoting cell growth of endocrine cells essentially consists of the combination of a basic nutritional mixture in which the amino acid Valine is provided in the racemic form D and a supplement in serum calf dialysis, growth factors and hormones.
  • This culture medium thus has the three desired properties:
  • This medium is therefore specially adapted to the cell culture of certain endocrine cells.
  • the culture medium has the following composition:
  • the culture medium has the following composition:
  • This culture medium will be called subsequently: PTCM.
  • This medium was used more particularly for the culture of parathyroid cells obtained from glands of hyperplastic adult subjects, adenomatous or normal, by enzymatic digestion, filtration or centrifugation in discontinuous Percoll gradient.
  • Figure 2 is a bar graph illustrating the chemiluminescence assay for a primary culture of parathormone (PTH) in culture supernatants
  • Figure 3 is a bar graph similar to bar graph 2 after first pass
  • Figure 4 represents curves of modifications of the secretion of PTH induced by the variation of the extra cellular calcium level.
  • Glandular samples were obtained, after consent of affected patients. After anatomo-pathological verification of the surgical patch in extemporaneous, the tissue fragment is placed in a sterile bottle containing physiological serum and then transported to the cell culture laboratory. It is then immediately treated or cryopreserved for subsequent cultivation.
  • the fragments obtained are rinsed to remove the residual blood and then weighed.
  • One of these samples is passed to ultrasound in order to determine its parathormone content.
  • Tissue digestion is obtained by incubation 45 to 60 minutes at 37 ° with mechanical agitation, by pipetting every 15 minutes in the following tampon - 20 mM HEPES. 136 mM NaCI, 4.7 mM KCI, 0.65 mM MgS04, 1 , 2 m
  • the cells are gently collected at each interface, washed with all traces of Percoll and then counted. Cell viability is determined by exclusion with Bleu Trypan. An aliquot of each suspension is kept to allow a measurement of its cellular PTH content.
  • Cell culture The cells are seeded at a density of 105 cells / cm2 in 24-well plates and incubated for 18 hours at 37 ° C in a base medium supplemented with 12% fetal calf serum. After this period, the medium is replaced by the PCTM medium.
  • the culture medium is removed, filtered, stored at -20 ° C. for the determination of PTH and replaced with fresh medium.
  • Antikeratin characterization of the epithelial nature of cells (mouse monoclonal antibody)
  • Anti Factor VIII indication of the presence or absence of endothelial cells in the cell monolayer (mouse monoclonal antibody)
  • Intact anti-PTH demonstration of the endocrine parathyroid character 2 & of the cells in culture by intra-cytoplasmic labeling (rabbit polyclonal antibody)
  • the cells during the primary culture and during the first subculture, were exposed for 2 hours to 35 variations in the concentration of extracellular calcium: passage of 0.62 mM (base rate in PTCM medium) at 1.8 mM. At the end of this incubation, the supernatants were removed and the assay of the parathormone
  • H LA DR antibodies The expression of H LA DR antibodies was studied by fluorescent immunostaining using a mouse monoclonal antibody. This labeling was carried out during all the stages of cell preparation, of the primary culture, during the first subculturing and after incubation for 48 hours of the cell monolayers with 200 U / ml of interferon g.
  • Percoll gradient centrifugation allowed the purification of endocrine parathyroid cells. Aliquots of cell suspension, obtained after Percoll gradient centrifugation, were cytocentrifuged and fixed.
  • Phase contrast optical microscopy highlights the cell types conventionally described in parathyroid tissue.
  • the viability of the fresh tissue is of the order of 80 to 90%; it decreases slightly for the cryopreserved tissue.
  • Cell adhesion is obtained 24 hours after sowing in the PTCM medium with an adhesion capacity of the order of 70%. Clones typical of epithelial cells appear from the second day and a cell monolayer is obtained within 6 to 8 days. The few fibroblastic type cells visible in the first days ( ⁇ 1%) do not proliferate thereafter.
  • the cell count curves represented in FIG. 1 of the appended schematic drawing show that the number of cells seeded in primary culture is restored under 8-10 days.
  • curve A the cell count was carried out in primary culture and on curve B in secondary culture at the first subculture.
  • the results represent the average carried out for triplicate tests for 3 independent cell strains.
  • curve A we see that on day D + 1 of the primary culture, 60 to 80
  • each cell contains PTH, whether in primary culture or at the end of the first subculture, which expresses the maintenance of cell differentiation.
  • the dosages of intact PTH are represented on the bar graph of Figures 2 and 3 (the duration, in days, is plotted on the x-axis and and the secretion of PTH on the y-axis).
  • A, B and C are 3 representative cell strains; the results express the average of the tests carried out in triplicate for each gland.
  • the assay of PTH in the culture supernatants was carried out by chemiluminescence: For FIG. 2, corresponding to the measurement of the secretion activity for 3 days of a primary culture, an average base rate of 34 is obtained, 6 pg / 105 cells / h for an extracellular calcium concentration of 0.62 mM.
  • Immunogenicity Some cells were positively labeled during anti-HLA DR immunostaining performed at the various stages of cell purification. This positive labeling is no longer detected within the cell monolayer throughout the culture even after stimulation of the expression of this class II molecules by interferon g.
  • This original formulation allows the survival and cellular multiplication of purified, functional and non-immunocompetent parathyroid endocrine cells.
  • the cells obtained by culture on the medium according to the invention are capable of application by grafting as an organ substitute.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A culture medium essentially consisting of a combination of a basic nutritive mixture in which the amino acid valine is present in racemic form D, and a dialysed foetal calf serum complement, as well as at least one epidermal growth factor, cholera toxin and hormones. The culture medium may be used for culturing certain endocrine cells capable of incorporating and decarboxylating bioamine precursors. The resulting cells may be used as organ substitutes in transplants.

Description

MILIEU DE CULTURE FAVORISANT LA CROISSANCE CELLULAIRE DES CULTURE MEDIUM PROMOTING CELL GROWTH
CELLULES ENDOCRINES La présente invention concerne un milieu de culture favorisant la croissance cellulaire de cellules endocrines.The present invention relates to a culture medium promoting cell growth of endocrine cells.
On connaît tous les problèmes que l'on rencontre quant on désire remédier aux insuffisances fonctionnelles organiques, innées ou acquises, des glandes endocrines. On a proposé plusieurs solutions qui se sont avérées insuffisantes pour de multiples raisons :We know all the problems we encounter when we want to remedy organic, innate or acquired functional insufficiencies of the endocrine glands. Several solutions have been proposed which have proved insufficient for multiple reasons:
- dans certains cas, du fait de leur instabilité, ou de l'impossibilité de les produire, la ou les hormones manquantes ne peuvent être délivrées sous forme de médicament- in certain cases, due to their instability, or the impossibility of producing them, the missing hormone (s) cannot be supplied in the form of a medicine
- quand cette ou ces hormones existent sous forme de médicament, la chronologie de leur administration est délicate : il est nécessaire de l'adapter aux variations physiologiques des métabolismes régulés- when this or these hormones exist in the form of a drug, the chronology of their administration is delicate: it is necessary to adapt it to the physiological variations of the regulated metabolisms
- la greffe d'organes allogènes est impossible ou tout au moins hautement improbable du fait de leur très haute immunogénicité- transplantation of allogenic organs is impossible or at least highly improbable due to their very high immunogenicity
- les cellules endocrines normales, prises isolément en dehors de toute contamination par d'autres cellules du tissu concerné sont non immunogènes.- normal endocrine cells, taken in isolation without any contamination by other cells of the tissue concerned, are non-immunogenic.
La solution idéale consisterait donc à remplacer les seules cellules concernées. Pour isoler ces cellules endocrines, il faut dissocier le tissu concerné puis préparer, par filtration ou centrifugation adaptée, une suspension cellulaire la plus enrichie possible en cellules endocrines. C'est la culture cellulaire de cette suspension qui constitue la deuxième étape indispensable de cette purification. Cette culture doit être sélective, pour ne conserver définitivement que les seules cellules endocrines ; elle doit être adaptée pour permettre la conservation des caractères fonctionnels de ces cellules ainsi que leur multiplication in vitro.The ideal solution would therefore consist in replacing the only cells concerned. To isolate these endocrine cells, it is necessary to dissociate the tissue concerned then prepare, by filtration or suitable centrifugation, a cell suspension as enriched as possible in endocrine cells. It is the cell culture of this suspension which constitutes the second essential step of this purification. This culture must be selective, in order to permanently conserve only the endocrine cells; it must be adapted to allow the conservation of the functional characteristics of these cells as well as their multiplication in vitro.
A l'heure actuelle, aucun milieu de culture ne remplit ces conditions.At present, no culture medium fulfills these conditions.
La présente invention s'est donnée pour objet de résoudre le problème posé ci-avant en proposant un nouveau milieu de culture constitué de l'association d'éléments nutritionnels et stimulants capables de répondre à la double exigence définie ci-dessus.The present invention is given for the purpose of solving the problem before it by providing a new culture medium consisting of the association of nutrients and stimulants able to meet the dual requirements defined above.
Pour définir ce mélange, les inventeurs ont choisi de considérer les cellules selon différentes approches jusqu'ici toujours dissociées :To define this mixture, the inventors have chosen to consider the cells according to different approaches hitherto always dissociated:
- les cellules ont été considérées selon leur origine exodermique, ce qui leur confère des exigences de cellules épithéliales- the cells were considered according to their exodermal origin, which gives them requirements for epithelial cells
- elles ont été considérées selon leur appartenance au système A.P.U.D (Aminé Precursor Uptake Decarboxylation ou cellules capables d'incorporer et de décarboxyler les précurseurs des aminés biogènes). Ces cellules, comme les cellules de la glande mammaire, sont alor capables d'utiliser un substrat d'acide aminé de forme racémique D (tel que la D Valine) capacité que ne possèdent pas les cellules les plus indésirables : fibroblastes, macrophages - elles ont été considérées selon leur nature endocrine, ce qui conduit à un enrichissement du mélange nutritionnel en plusieurs facteurs stimulants connus pour leur influence sur l'expression des fonctionnalités des cellule différenciées.- they have been considered according to their belonging to the APUD system (Amine Precursor Uptake Decarboxylation or cells capable of incorporating and decarboxylating the precursors of biogenic amines). These cells, like the cells of the mammary gland, are then capable of using an amino acid substrate of racemic form D (such as D Valine) capacity which the most undesirable cells do not have: fibroblasts, macrophages - do they have been considered according to their endocrine nature, which leads to an enrichment of the nutritional mixture with several stimulating factors known for their influence on the expression of the functionalities of the differentiated cells.
Au cours de leurs recherches, les inventeurs ont pu déterminer qu'il était essentiel que ce milieu de culture ne renferme aucune trace de L Valine ; ils ont donc, d'une part remplacé dans la solution de base la L Valine par la D Valine et d'autre part employé, pour la complémentation, du sérum de veau foetal dialyse, additionné de facteurs de croissance et d'hormones.During their research, the inventors were able to determine that it was essential that this culture medium does not contain any trace of L Valine; they therefore, on the one hand replaced in the basic solution L Valine by D Valine and on the other hand used, for the complementation, fetal calf serum dialysis, supplemented with growth factors and hormones.
Certains milieux ont été proposés pour la culture des cellules mammaires. Plusieurs milieux de culture utilisent la MEM D Valine (CELL BIOLOGY INTERNATIONAL REPORTS, vol. 12 n° 5 Mai 1988, pp. 355-364), additionnée éventuellement de sérum de veau foetal et d'insuline (IN VITRO Vol 14, n° 3, Mars 1978, Rockville MD US pp 271-281 ), (IN VITRO Vol 18, n° 4, Avril 1982, Rockville MD US pp 407-414). US-A-4 423 145 décrit des milieux de culture classiques, à base de L Valine, associés à des facteurs de croissance et à des hormones.Certain media have been proposed for the culture of mammary cells. Several culture media use MEM D Valine (CELL BIOLOGY INTERNATIONAL REPORTS, vol. 12 no.5 May 1988, pp. 355-364), optionally supplemented with fetal calf serum and insulin (IN VITRO Vol 14, no. 3, March 1978, Rockville MD US pp 271-281), (IN VITRO Vol 18, n ° 4, April 1982, Rockville MD US pp 407-414). US-A-4,423,145 describes conventional culture media, based on L Valine, associated with growth factors and hormones.
Le milieu de culture favorisant la croissance cellulaire de cellules endocrines selon l'invention est essentiellement constitué de l'association d'un mélange nutritionnel de base dans lequel l'acide aminé Valine est apporté sous la forme racémique D et d'un complément en sérum de veau foetal dialyse, de facteurs de croissance et d'hormones.The culture medium promoting cell growth of endocrine cells according to the invention essentially consists of the combination of a basic nutritional mixture in which the amino acid Valine is provided in the racemic form D and a supplement in serum calf dialysis, growth factors and hormones.
Ce milieu de culture présente ainsi les trois propriétés désirées :This culture medium thus has the three desired properties:
- sélectivité- selectivity
- réponse aux besoins en facteurs différenciants- response to the need for differentiating factors
- réponse aux besoins en facteurs stimulants Ce milieu est donc tout spécialement adapté à la culture cellulaire de certaines cellules endocrines.- response to the need for stimulating factors This medium is therefore specially adapted to the cell culture of certain endocrine cells.
Selon un mode de réalisation particulier de l'invention, le milieu de culture présente la composition suivante :According to a particular embodiment of the invention, the culture medium has the following composition:
- solution de base : MEM (milieu essentiel minimum) D Valine (sel de Earle + D Valine)- basic solution: MEM (minimum essential medium) D Valine (Earle salt + D Valine)
- complémentation:- complementation:
- Sérum de veau dialyse (18h contre une membrane de cellulose régénérée, porosité 1000 da) 0,02 à 0,20 ml/ml- Calf dialysis serum (6 p.m. against a cellulose membrane regenerated, porosity 1000 da) 0.02 to 0.20 ml / ml
- Facteur de croissance épidermique 1 à 50 ng/ml- Epidermal growth factor 1 to 50 ng / ml
- Insuline 0,001 à 20 mg/ml- Insulin 0.001 to 20 mg / ml
- Hydrocortisone 0,004 à 5 mg/ml - Transferrine 0,5 à 100 mg/ml- Hydrocortisone 0.004 to 5 mg / ml - Transferrin 0.5 to 100 mg / ml
- Toxine cholérique 10 -8 à 10 -12 M- Cholera toxin 10 -8 to 10 -12 M
- 3,3'-5 Triiodo L Thyronine 2.10 -i à 2.10 -11 M- 3.3'-5 Triiodo L Thyronine 2.10 -i to 2.10 -11 M
- Extrait pituitaire bovin 0,05 à 100 mg/ml Ce milieu sera dénommé par la suite : APUDCM Selon un autre mode de réalisation préféré de l'invention, le milieu de culture présente la composition suivante :- Bovine pituitary extract 0.05 to 100 mg / ml This medium will be called hereinafter: APUDCM According to another preferred embodiment of the invention, the culture medium has the following composition:
- solution de base : MEM D Valine (sel de Earle + D Valine)- basic solution: MEM D Valine (Earle salt + D Valine)
- complémentation:- complementation:
- Sérum de veau dialyse (18h contre une membrane de cellulose régénérée, porosité 1000 da) 0,12 ml/ml- Calf serum dialysis (18h against a regenerated cellulose membrane, porosity 1000 da) 0.12 ml / ml
- Facteur de croissance épidermique 10 ng/ml- Epidermal growth factor 10 ng / ml
- Insuline 5 mg/ml- Insulin 5 mg / ml
- Hydrocortisone 400 ng/ml - Transferrine 5 mg/ml - Toxine cholérique 10 -ιo M- Hydrocortisone 400 ng / ml - Transferrin 5 mg / ml - Cholera toxin 10 -ιo M
- 3,3'-5 Triiodo L Thyronine 2.10 -9 M- 3.3'-5 Triiodo L Thyronine 2.10 -9 M
- Extrait pituitaire bovin 5 mg/ml- Bovine pituitary extract 5 mg / ml
Ce milieu de culture sera dénommé par la suite : PTCM.This culture medium will be called subsequently: PTCM.
Ce milieu a été utilisé plus particulièrement pour la culture des cellules parathyroidiennes obtenues à partir de glandes de sujets adultes hyperplasiques, adénomateuses ou normales, par digestion enzymatique, filtration ou centrifugation en gradient de Percoll discontinu.This medium was used more particularly for the culture of parathyroid cells obtained from glands of hyperplastic adult subjects, adenomatous or normal, by enzymatic digestion, filtration or centrifugation in discontinuous Percoll gradient.
La présente invention sera bien comprise à l'aide de la description suivante qui l'illustre sans nullement la limiter ainsi que du dessin schématique annexé représentant certains des résultats obtenus. Dans le dessin schématique :The present invention will be clearly understood with the aid of the following description which illustrates it without in any way limiting it, as well as the appended schematic drawing representing some of the results obtained. In the schematic drawing:
Figure 1 représente les courbes de numération cellulaireFigure 1 shows the cell count curves
Figure 2 est un graphique-barre illustrant le dosage en chimiluminescence pour une culture primaire de la parathormone (PTH) dans les surnageants de cultureFigure 2 is a bar graph illustrating the chemiluminescence assay for a primary culture of parathormone (PTH) in culture supernatants
Figure 3 est un graphique-barre similaire au graphique-barre 2 après premier passageFigure 3 is a bar graph similar to bar graph 2 after first pass
Figure 4 représente des courbes de modifications de la sécrétion de PTH induite par la variation du taux de calcium extra cellulaire. Obtention de la préparation cellulaireFigure 4 represents curves of modifications of the secretion of PTH induced by the variation of the extra cellular calcium level. Obtaining cell preparation
Des échantillons glandulaires ont été obtenus, après consentement de malades concernés. Après vérification anatomo-pathologique de la pièc chirurgicale en extemporané, le fragment tissulaire est placé dans un flacon stéril contenant du sérum physiologique puis transporté au laboratoire de culture cellulaires. Il est alors immédiatement traité ou cryopréservé en vue d'une mise e culture ultérieure.Glandular samples were obtained, after consent of affected patients. After anatomo-pathological verification of the surgical patch in extemporaneous, the tissue fragment is placed in a sterile bottle containing physiological serum and then transported to the cell culture laboratory. It is then immediately treated or cryopreserved for subsequent cultivation.
Après un découpage fin de l'échantillon, les fragments obtenus so rincés pour éliminer le sang résiduel puis pesés. Un de ces échantillons est pass aux ultra-sons afin de déterminer son contenu en parathormone.After a fine cutting of the sample, the fragments obtained are rinsed to remove the residual blood and then weighed. One of these samples is passed to ultrasound in order to determine its parathormone content.
La digestion tissulaire est obtenue par incubation 45 à 60 minutes à 37° avec agitation mécanique, par pipettage toutes les 15 minutes dans le tampo suivant - 20 mM HEPES.136 mM NaCI, 4,7 mM KCI, 0,65 mM MgS04, 1 ,2 mTissue digestion is obtained by incubation 45 to 60 minutes at 37 ° with mechanical agitation, by pipetting every 15 minutes in the following tampon - 20 mM HEPES. 136 mM NaCI, 4.7 mM KCI, 0.65 mM MgS04, 1 , 2 m
CaCI2CaCI2
- 1 ,5 mg/ml collagénase- 1.5 mg / ml collagenase
- 40 mg/ml DNAse- 40 mg / ml DNAse
- pH 7,45 La suspension cellulaire obtenue est filtrée à 25 mm puis incubée 3 minute dans le tampon EGTA suivant : - 1 mM EGTA- pH 7.45 The cell suspension obtained is filtered at 25 mm and then incubated for 3 minutes in the following EGTA buffer: - 1 mM EGTA
- 20 mM HEPES, 142 mM NaCI, 07 mM KCI- 20 mM HEPES, 142 mM NaCI, 07 mM KCI
- pH 7,4 On réalise ainsi la dissociation des agrégats cellulaires.- pH 7.4 The cell aggregates are thus dissociated.
La purification des cellules parathyroidiennes est effectuée pa centrifugation de la suspension cellulaire sur gradient discontinu de Percoll. L dilution d'une solution stock isotonique de Percoll (d = 1 ,123) avec une solutio saline de Hanks (d = 1 ,006) permet d'obtenir 3 solutions de densité 1 ,035, 1 ,058 e 1 ,090. La centrifugation est réalisée à 2000 tours /mn pendant 20 mn avec un accélération et une décélération minimale.The purification of the parathyroid cells is carried out by centrifugation of the cell suspension on a discontinuous Percoll gradient. Diluting a Percoll isotonic stock solution (d = 1.123) with a Hanks saline solution (d = 1.006) makes it possible to obtain 3 solutions of density 1.035, 1.058 and 1.090. Centrifugation is carried out at 2000 rpm for 20 min with minimum acceleration and deceleration.
Les cellules sont récupérées délicatement à chaque interface, lavées d toute trace de Percoll puis comptées. La viabilité cellulaire est déterminée pa exclusion au Bleu Trypan. Un aliquote de chaque suspension est conservé pou permettre une mesure de son contenu cellulaire en PTH. Culture cellulaire Les cellules sont ensemencées à la densité de 105 cellules/cm2 dans des plaques 24 puits et incubées 18 heures à 37°C dans un milieu de base supplémenté à 12 % de sérum de veau foetal. Après cette période, le milieu est remplacé par le milieu PCTM.The cells are gently collected at each interface, washed with all traces of Percoll and then counted. Cell viability is determined by exclusion with Bleu Trypan. An aliquot of each suspension is kept to allow a measurement of its cellular PTH content. Cell culture The cells are seeded at a density of 105 cells / cm2 in 24-well plates and incubated for 18 hours at 37 ° C in a base medium supplemented with 12% fetal calf serum. After this period, the medium is replaced by the PCTM medium.
Tous les trois jours, le milieu de culture est prélevé, filtré, conservé à -20°C 5 en vue du dosage de PTH et remplacé par du milieu frais.Every three days, the culture medium is removed, filtered, stored at -20 ° C. for the determination of PTH and replaced with fresh medium.
A confluence, les cellules sont détachées par l'action d'une solution de trypsine-EDTA. La culture cellulaire est alors poursuivie sous deux formes :At confluence, the cells are detached by the action of a solution of trypsin-EDTA. Cell culture is then pursued in two forms:
- ensemencement en plaques 24 puits à raison de 1 ,5.105 cellules/puit dans le but d'estimer la croissance cellulaire ; on effectue la numération 245 heures après- inoculation in 24-well plates at a rate of 1, 5.105 cells / well in order to estimate cell growth; we count 245 hours after
!£> l'ensemencement puis tous les 3 jours en triplicate. ! £> seeding then every 3 days in triplicate.
- ensemencement en boîtes de Pétri, à la densité de 105 cellules/cm2 afin de poursuivre la culture.- seeding in Petri dishes, at a density of 105 cells / cm2 in order to continue the culture.
Caractérisation cellulaire Les différents examens de caractérisation cellulaire ont été effectués selon les techniques suivantes : 15 - Microscopie optique : une coloration cellulaire par le réactif May GrunwaldCell characterization The various cell characterization examinations were carried out according to the following techniques: 15 - Optical microscopy: cell staining with the May Grunwald reagent
Giemsa permet de caractériser les différents types de cellules parenchymateusesGiemsa allows to characterize the different types of parenchymal cells
- Microscopie électronique : on a observé des sections cellulaires ultrafines, réalisées en culture secondaire.- Electron microscopy: ultra-fine cell sections, observed in secondary culture, were observed.
- Immunomarquages:- Immunolabels:
20 Antikératine : caractérisation de la nature épithéliale des cellules (anticorps monoclonal de souris) 20 Antikeratin: characterization of the epithelial nature of cells (mouse monoclonal antibody)
Anti Facteur VIII : indication de la présence ou de l'absence de cellules endothéliales dans la monocouche cellulaire (anticorps monoclonal de souris)Anti Factor VIII: indication of the presence or absence of endothelial cells in the cell monolayer (mouse monoclonal antibody)
Anti PTH intacte : mise en évidence du caractère endocrine parathyroïdien 2& des cellules en culture par un marquage intra-cytoplasmique (anticorps polyclonal de lapin)Intact anti-PTH: demonstration of the endocrine parathyroid character 2 & of the cells in culture by intra-cytoplasmic labeling (rabbit polyclonal antibody)
Fonctionnalité des cellules en culture. Elle a été étudiée comme suit :Functionality of cells in culture. It has been studied as follows:
- Les dosages de la PTH intacte ont été réalisés en chimiluminescence à 30 l'aide de la trousse de dosage "Magic Lite Intact PTH" commercialisée par Ciba- assays intact PTH was made in chemiluminescence 0 to 3 using the assay kit "Magic Lite Intact PTH" sold by Ciba
Corning, tant sur le tissu initial que sur les cellules purifiées et dans les surnageants de culture.Corning, both on the initial tissue and on the purified cells and in the culture supernatants.
- Pour la détermination de la sensibilité au calcium, les cellules, durant la culture primaire et lors du premier repiquage, ont été exposées pendant 2 heures à des 35 variations de la concentration en calcium extracellulaire : passage de 0,62 mM (taux de base dans le milieu PTCM) à 1 ,8 mM. Au terme de cette incubation, les surnageants ont été prélevés et l'on a effectué le dosage de la parathormone- For the determination of the sensitivity to calcium, the cells, during the primary culture and during the first subculture, were exposed for 2 hours to 35 variations in the concentration of extracellular calcium: passage of 0.62 mM (base rate in PTCM medium) at 1.8 mM. At the end of this incubation, the supernatants were removed and the assay of the parathormone
ImmunoqénicitéImmunoqenicity
- L'expression des anticorps H LA DR a été étudié par immunomarquage en fluorescence à l'aide d'un anticorps monoclonal de souris. Ce marquage a ét réalisé durant toutes les étapes de la préparation cellulaire, de la culture primaire, lors du premier repiquage et après incubation durant 48 heures des monocouche cellulaires avec 200 U/ml d'interféron g.- The expression of H LA DR antibodies was studied by fluorescent immunostaining using a mouse monoclonal antibody. This labeling was carried out during all the stages of cell preparation, of the primary culture, during the first subculturing and after incubation for 48 hours of the cell monolayers with 200 U / ml of interferon g.
- Cultures mixtes : cultures réalisées avec des cellules parathyroidienne irradiées à 2500 rad. selon le protocole de Saxe (Surgery 1990 108 :56-62 : "In vitro assessment of parathyroid immunogenicity") . RESULTATS.- Mixed cultures: cultures carried out with parathyroid cells irradiated at 2500 rad. according to the Saxony protocol (Surgery 1990 108: 56-62: "In vitro assessment of parathyroid immunogenicity"). RESULTS.
Purification et culture cellulairePurification and cell culture
La centrifugation sur gradient de Percoll a permis la purification de cellule parathyroidiennes endocrines. Des aliquotes de suspension cellulaire, obtenus après centrifugation en gradient de Percoll, ont été cytocentrifugés et fixés.Percoll gradient centrifugation allowed the purification of endocrine parathyroid cells. Aliquots of cell suspension, obtained after Percoll gradient centrifugation, were cytocentrifuged and fixed.
Une coloration en réactif May Grunwald Giemsa a permis la caractérisation des types cellulaires isolés pour chaque densité (x 100) :Staining with May Grunwald Giemsa reagent allowed the characterization of the isolated cell types for each density (x 100):
La microscopie optique en contraste de phase met en évidence les types cellulaires classiquement décrits dans le tissu parathyroïdien.Phase contrast optical microscopy highlights the cell types conventionally described in parathyroid tissue.
- 1035 g/ml - essentiellement cellules graisseuses et débris cellulaires -1 ,058 g/ml - petites cellules principales avec quelques cellules oxyphiles -1 ,090 g/ml - cellules principales.- 1035 g / ml - mainly fat cells and cellular debris -1.058 g / ml - small main cells with some oxyphilic cells -1.090 g / ml - main cells.
La viabilité du tissu frais est de l'ordre de 80 à 90 % ; elle décroît légèrement pour le tissu cryopréservé.The viability of the fresh tissue is of the order of 80 to 90%; it decreases slightly for the cryopreserved tissue.
30 à 40 % du matériel glandulaire initial est récupéré après la centrifugation sur Percoll : 52,82 ng à 120,68 ng de PTH/g de tissu initial pour 12,76 πg à 49,92 ng de PTH/g de cellules après Percoll.30 to 40% of the initial glandular material is recovered after centrifugation on Percoll: 52.82 ng to 120.68 ng of PTH / g of initial tissue for 12.76 πg to 49.92 ng of PTH / g of cells after Percoll .
L'adhésion cellulaire est obtenue 24 heures après l'ensemencement dans le milieu PTCM avec une capacité d'adhésion de l'ordre de 70 %. Des clones typiques des cellules épithéliales apparaissent dès le deuxième jour et une monocouche cellulaire est obtenue sous 6 à 8 jours. Les quelques cellules de type fibroblastique visibles les premiers jours (< 1%) ne prolifèrent pas par la suite.Cell adhesion is obtained 24 hours after sowing in the PTCM medium with an adhesion capacity of the order of 70%. Clones typical of epithelial cells appear from the second day and a cell monolayer is obtained within 6 to 8 days. The few fibroblastic type cells visible in the first days (<1%) do not proliferate thereafter.
Les courbes de numération cellulaire représentées à la figure 1 du dessin schématique annexé, (la durée, en jours, étant portée en abscisses et le nombre de cellules ensemencées en ordonnées) mettent en évidence que le nombre de cellules ensemencées en culture primaire est restauré sous 8 à 10 jours. Sur la courbe A, la numération cellulaire a été réalisée en culture primaire et sur la courbe B en culture secondaire au premier repiquage. Les résultats représentent la moyenne réalisée pour des essais en triplicate pour 3 souches cellulaires indépendantes. , Sur la courbe A, on constate qu'au jour J + 1 de la culture primaire, 60 à 80The cell count curves represented in FIG. 1 of the appended schematic drawing (the duration, in days, being plotted on the abscissa and the number of cells seeded on the ordinate) show that the number of cells seeded in primary culture is restored under 8-10 days. On curve A, the cell count was carried out in primary culture and on curve B in secondary culture at the first subculture. The results represent the average carried out for triplicate tests for 3 independent cell strains. , On curve A, we see that on day D + 1 of the primary culture, 60 to 80
% des cellules ensemencées ont adhéré. Leur nombre initial est restauré sous 8 à 10 jours.% of the seeded cells have adhered. Their initial number is restored within 8 to 10 days.
Sur la courbe B, on constate que l'adhésion des cellules est diminuée lors du passage en culture secondaire ; au jour J + 1 , 30 à 50 % des cellules adhèrent ; cependant, à J + 10, on atteint 80 % du nombre initial de cellules.On curve B, it can be seen that the adhesion of the cells is reduced during the transition to secondary culture; on day D + 1, 30 to 50% of the cells adhere; however, at D + 10, 80% of the initial number of cells is reached.
Les meilleurs résultats sont obtenus lorsque le passage se fait à subconfluence ; il a été possible alors d'effectuer 3 à 5 passages avant l'apparition de la sénescence cellulaire.The best results are obtained when the transition is made to subconfluence; it was then possible to make 3 to 5 passages before the appearance of cellular senescence.
Caractérisation cellulaire : L'examen en microscopie électronique a démontré la nature endocrine des cellules en culture. L'ultra structure correspond à celle de cellules principales actives contenant des grains de sécrétion, un appareil de Golgi et un réticulum endoplasmique actif, cellules décrites dans le tissu parathyroïdien normal ou adénomateux. (Weymouth R.J. et Sheridans M.N. - 1966 - Acta Endocrinol. 53 : 529- 546 et Thiele J. Dârner J. and Fischer R - 1988 : - J. Submicros. Cytol. Pathol. 20 (3) : 491-500).Cell characterization: Examination by electron microscopy demonstrated the endocrine nature of cells in culture. The ultra structure corresponds to that of active main cells containing secretory grains, a Golgi apparatus and an active endoplasmic reticulum, cells described in normal or adenomatous parathyroid tissue. (Weymouth R.J. and Sheridans M.N. - 1966 - Acta Endocrinol. 53: 529-546 and Thiele J. Dârner J. and Fischer R - 1988: - J. Submicros. Cytol. Pathol. 20 (3): 491-500).
Les immunomarquages, réalisés sur des cultures primaires et lors du premier passage ont donné les résultats suivants :Immunostaining, performed on primary cultures and during the first pass, gave the following results:
- Dans le cas de l'immunomarquage antikératine humaine, on relève un marquage positif des filaments intermédiaires dans toute la population cellulaire ; le contrôle réalisé avec un sérum non-immun de souris à la place du premier anticorps est négatif, ce qui révèle la nature exclusivement épithéliale des cellules (Miettinen M. et al. 1985 - Arch. Pathol. Lab. Med. 109 : 986-989).- In the case of human anti-keratin immunolabelling, there is a positive labeling of the intermediate filaments throughout the cell population; the control carried out with a non-immune mouse serum in place of the first antibody is negative, which reveals the exclusively epithelial nature of the cells (Miettinen M. et al. 1985 - Arch. Pathol. Lab. Med. 109: 986- 989).
- Dans le cas de l'immunomarquage anti-facteur VIII humain, on constate l'absence de cellules endotheliales au cours de la phase de culture cellulaire. La spécificité du marquage est confirmée par la présence de cellules marquées positivement après la digestion enzymatique.- In the case of anti-human factor VIII immunostaining, the absence of endothelial cells is observed during the cell culture phase. The specificity of the labeling is confirmed by the presence of positively labeled cells after the enzymatic digestion.
- Dans le cas de l'immunomarquage anti-PTH intacte humaine, l'anticorps anti-PTH marque positivement toutes les cellules fixées tant en culture primaire que lors du premier passage ; les contrôles réalisés avec un sérum de lapin à la place du premier anticorps ne révèlent aucune fluorescence. On met ainsi en évidence la nature endocrine des cellules : chaqu cellule contient de la PTH, que ce soit en culture primaire ou à la fin du premie repiquage, ce qui exprime le maintien de la différenciation cellulaire.- In the case of intact human anti-PTH immunostaining, the anti-PTH antibody positively labels all the cells fixed both in primary culture and during the first passage; the controls carried out with a rabbit serum in place of the first antibody do not reveal any fluorescence. We thus highlight the endocrine nature of cells: each cell contains PTH, whether in primary culture or at the end of the first subculture, which expresses the maintenance of cell differentiation.
Fonctionnalité - Les dosages de PTH intacte sont représentés sur le graphiques-barre des figures 2 et 3 (la durée, en jours, est portée en abscisses et et la sécrétion de PTH en ordonnées). Sur les deux figures, A, B et C sont 3 souche cellulaires représentatives ; les résultats expriment la moyenne des essais réalisé en triplicate pour chaque glande. Le dosage de la PTH dans les surnageants d culture a été réalisé en chimiluminescence : Pour la figure 2, correspondant à la mesure de l'activité de sécrétio pendant 3 jours d'une culture primaire, on obtient un taux de base moyen de 34,6 pg/105 cellules/h pour une concentration de calcium extracellulaire de 0,62 mM.Functionality - The dosages of intact PTH are represented on the bar graph of Figures 2 and 3 (the duration, in days, is plotted on the x-axis and and the secretion of PTH on the y-axis). In the two figures, A, B and C are 3 representative cell strains; the results express the average of the tests carried out in triplicate for each gland. The assay of PTH in the culture supernatants was carried out by chemiluminescence: For FIG. 2, corresponding to the measurement of the secretion activity for 3 days of a primary culture, an average base rate of 34 is obtained, 6 pg / 105 cells / h for an extracellular calcium concentration of 0.62 mM.
Pour la figure 3, après un premier passage, on relève un taux de sécrétio moyen de 34,39 pg/105 cellules/h . L'étude de la modification de la sécrétion de PTH induite par la variation d taux de calcium extracellulaire est représentée sur les courbes de la figure 4 (l durée, en heures, est portée en abscisses et la sécrétion de PTH en ordonnées) Sur ces courbes les résultats représentent une moyenne de 3 essais indépendants réalisés en triplicate. Les cellules à confluence lors du premier passage ont ét incubées 2 h dans le milieu PCTM à des taux de calcium de 0,62 mM (taux de base et de 1 ,8 mM.For FIG. 3, after a first pass, an average secretion rate of 34.39 pg / 105 cells / h is noted. The study of the modification of the secretion of PTH induced by the variation of extracellular calcium level is represented on the curves of FIG. 4 (the duration, in hours, is plotted on the abscissa and the secretion of PTH on the ordinate) On these curves the results represent an average of 3 independent tests carried out in triplicate. The cells at confluence during the first passage were incubated for 2 h in PCTM medium at calcium levels of 0.62 mM (base level and 1.8 mM.
On voit qu'une augmentation du taux de calcium de 0,62 mM à 1 ,8 m induit une diminution de la sécrétion de PTH intacte d'environ 40 % du taux de base cette modification correspond à la régulation normale des cellule parathyroidiennes dans les conditions physiologiques in vivo. (Brown et al. Am. JIt can be seen that an increase in the level of calcium from 0.62 mM to 1.8 m induces a decrease in the secretion of intact PTH by approximately 40% of the basic rate. This modification corresponds to the normal regulation of the parathyroid cells in the physiological conditions in vivo. (Brown et al. Am. J
Med. 66 : 923 - 931).Med. 66: 923-931).
Immunogénéicité - Quelques cellules ont été marquées positivement lors d Timmunomarquage anti HLA DR réalisé aux différentes étapes de la purificatio cellulaire. Ce marquage positif n'est plus détecté au sein de la monocouche cellulair tout le long de la culture même après une stimulation de l'expression de ce molécules de classe II par l'interféron g.Immunogenicity - Some cells were positively labeled during anti-HLA DR immunostaining performed at the various stages of cell purification. This positive labeling is no longer detected within the cell monolayer throughout the culture even after stimulation of the expression of this class II molecules by interferon g.
Les résultats présentés dans la table suivante montrent la capacité de lymphocytes T à réagir à une stimulation par la Concanavaline A ainsi que leu absence de réaction aux cellules parathyroidiennes purifiées, ce qui confirme la no immunogénicité de ces dernières. Co-culture cellules parathyroidiennes (PTHvmphocvtes (Lvm)The results presented in the following table show the capacity of T lymphocytes to react to stimulation by Concanavalin A as well as their absence of reaction to purified parathyroid cells, which confirms the no immunogenicity of the latter. Co-culture of parathyroid cells (PTHvmphocvtes (Lvm)
Suspension cellulaire Cellules par puits Incorporation thymidine tritiée Lym PT (impulsions/min)Cell suspension Cells per well Incorporation of tritiated thymidine Lym PT (pulses / min)
Moyenne SEMSEM average
PT irradiées 105 342 38PT irradiated 105 342 38
Lym/PT irradiées 105 105 444 175Lym / PT irradiated 105 105 444 175
Lym 105 148 94Lym 105 148 94
Lym +Concanavalin A) 105 1992 582Lym + Concanavalin A) 105 1992 582
(0,25 mg puit)(0.25 mg well)
La description qui précède montre bien l'originalité de la formulation du milieu de culture proposé, qui associe des constituants connus pour leur capacité à maintenir les propriétés des cellules endocrines et à permettre la prolifération des cellules epitheliales, avec un acide aminé particulier, la D Valine qui assure, par l'élimination des cellules parasites : fibroblastes, macrophages, la sélection des seules cellules endocrines.The above description clearly shows the originality of the formulation of the proposed culture medium, which combines constituents known for their ability to maintain the properties of endocrine cells and to allow the proliferation of epithelial cells, with a particular amino acid, D Valine which ensures, by eliminating parasitic cells: fibroblasts, macrophages, the selection of only endocrine cells.
Cette formulation originale autorise la survie et la multiplication cellulaire de cellules endocrines parathyroidiennes purifiées, fonctionnelles et non imunnocompétentes.This original formulation allows the survival and cellular multiplication of purified, functional and non-immunocompetent parathyroid endocrine cells.
La similitude d'équipement enzymatique qui permet aux cellules parathyroidiennes et aux cellules de la glande mammaire de convertir l'acide aminé D Valine et L Valine, ainsi que des résultats préliminaires avec les cellules b des îlots de Langerhaus permet de penser que cet équipement enzymatique peut être commun à de nombreuses cellules endocrines.The similarity of enzymatic equipment which allows the parathyroid cells and the cells of the mammary gland to convert the amino acid D Valine and L Valine, as well as preliminary results with the b cells of the islets of Langerhaus suggests that this enzymatic equipment may be common to many endocrine cells.
Les cellules obtenues par culture sur le milieu selon l'invention sont susceptibles d'application par greffage comme substitut d'organe. The cells obtained by culture on the medium according to the invention are capable of application by grafting as an organ substitute.

Claims

REVENDICATIONS
1 - Milieu de culture favorisant la croissance cellulaire de cellules endocrines caractérisé en ce qu'il est essentiellement constitué de l'association d'un mélange nutritionnel de base dans lequel l'acide aminé Valine est apporté sous la forme racémique D et d'un complément en sérum de veau foetal dialyse, additionné d'au moins un facteur de croissance épidermique, de toxine cholérique et d'hormones.1 - Culture medium promoting cell growth of endocrine cells characterized in that it essentially consists of the association of a basic nutritional mixture in which the amino acid Valine is provided in the racemic form D and of a supplement in fetal calf serum dialysis, supplemented with at least one epidermal growth factor, cholera toxin and hormones.
2 - Milieu de culture selon la revendication 1 caractérisé en ce qu'il présente la composition suivante :2 - Culture medium according to claim 1 characterized in that it has the following composition:
- solution de base : MEM D Valine (sel de Earle + D Valine) - complémentation: - Sérum de veau dialyse (18h contre une membrane de cellulose régénérée, porosité 1000 da) 0,02 à 0,20 ml/ml- basic solution: MEM D Valine (Earle salt + D Valine) - supplementation: - Calf serum dialysis (18h against a regenerated cellulose membrane, porosity 1000 da) 0.02 to 0.20 ml / ml
- Facteur de croissance épidermique 1 à 50 ng/ml- Epidermal growth factor 1 to 50 ng / ml
- Insuline 0,001 à 20 mg/ml- Insulin 0.001 to 20 mg / ml
- Hydrocortisone 0,004 à 5 mg/ml - Transferrine 0,5 à 100 mg/ml- Hydrocortisone 0.004 to 5 mg / ml - Transferrin 0.5 to 100 mg / ml
- Toxine cholérique 10 -8 à 10 -12 M- Cholera toxin 10 -8 to 10 -12 M
- 3,3'-5 Triiodo L Thyronine 2.10 -7 à 2.10 -11 M- 3.3'-5 Triiodo L Thyronine 2.10 -7 to 2.10 -11 M
- Extrait pituitaire bovin 0,05 à 100 mg/ml- Bovine pituitary extract 0.05 to 100 mg / ml
3 - Milieu de culture selon la revendication 2 caractérisé en ce qu'il présente la composition suivante :3 - Culture medium according to claim 2 characterized in that it has the following composition:
- solution de base : MEM D Valine (sel de Earle + D Valine) - complémentation: - Sérum de veau dialyse (18h contre une membrane de cellulose régénérée, porosité 1000 da) 0,12 ml/ml- basic solution: MEM D Valine (Earle salt + D Valine) - supplementation: - Calf serum dialysis (18h against a regenerated cellulose membrane, porosity 1000 da) 0.12 ml / ml
- Facteur de croissance épidermique 10 ng/ml - Insuline 5 mg/ml- Epidermal growth factor 10 ng / ml - Insulin 5 mg / ml
- Hydrocortisone 400 ng/ml- Hydrocortisone 400 ng / ml
- Transferrine 5 mg/ml- Transferrin 5 mg / ml
- Toxine cholérique 10 -10 M- Cholera toxin 10 -10 M
- 3,3'-5 Triiodo L Thyronine 2.10 -9 M - Extrait pituitaire bovin 5 mg/ml- 3.3'-5 Triiodo L Thyronine 2.10 -9 M - Bovine pituitary extract 5 mg / ml
4 - Application du milieu de culture selon l'une quelconque des revendications 1 à 3 à la culture cellulaire de certaines cellules endocrines capables d'incorporer et de décarboxyler les précurseurs des aminés biogènes4 - Application of the culture medium according to any one of claims 1 to 3 to the cell culture of certain endocrine cells capable of incorporating and decarboxylating the precursors of biogenic amines
5 - Cellules obtenues par culture sur le milieu selon l'une quelconque des revendications 1 à 4 pour utilisation comme substitut d'organe. 5 - Cells obtained by culture on the medium according to any one of claims 1 to 4 for use as an organ substitute.
PCT/FR1995/000961 1994-07-22 1995-07-18 Culture medium promoting endocrine cell growth WO1996003496A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU30799/95A AU3079995A (en) 1994-07-22 1995-07-18 Culture medium promoting endocrine cell growth

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR94/09330 1994-07-22
FR9409330A FR2722797A1 (en) 1994-07-22 1994-07-22 CULTURE MEDIUM PROMOTING CELL GROWTH OF ENDOCRINE CELLS

Publications (1)

Publication Number Publication Date
WO1996003496A1 true WO1996003496A1 (en) 1996-02-08

Family

ID=9465820

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1995/000961 WO1996003496A1 (en) 1994-07-22 1995-07-18 Culture medium promoting endocrine cell growth

Country Status (3)

Country Link
AU (1) AU3079995A (en)
FR (1) FR2722797A1 (en)
WO (1) WO1996003496A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423145A (en) * 1981-05-07 1983-12-27 Stampfer Martha R Enhanced growth medium and method for culturing human mammary epithelial cells
WO1994023572A1 (en) * 1993-04-08 1994-10-27 Human Cell Cultures, Inc. Cell culturing method and medium

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423145A (en) * 1981-05-07 1983-12-27 Stampfer Martha R Enhanced growth medium and method for culturing human mammary epithelial cells
WO1994023572A1 (en) * 1993-04-08 1994-10-27 Human Cell Cultures, Inc. Cell culturing method and medium

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
L.M. SORDILLO ET AL.: "CULTURE OF BOVINE MAMMARY EPITHELIAL CELLS IN D-VALINE MODIFIED MEDIUM: SELECTIVE REMOVAL OF CONTAMINATING FIBROBLASTS.", CELL BIOLOGY INTERNATIONAL REPORTS, vol. 12, no. 5, LONDON, GB, pages 355 - 364 *
M.T. WHITE ET AL.: "IN VITRO ANALYSIS OF PROLIFERATING EPITHELIAL CELL POPULATIONS FROM THE MOUSE MAMMARY GLAND: FIBROBLAST-FREE GROWTH AND SERIAL PASSAGE.", IN VITRO, vol. 14, no. 3, ROCKVILLE, MD., US, pages 271 - 281 *
U.K. EHMANN ET AL.: "MOUSE MAMMARY CELLS IN D-VALINE MEDIUM.", IN VITRO, vol. 18, no. 4, ROCKVILLE, MD., US, pages 407 - 414 *

Also Published As

Publication number Publication date
FR2722797A1 (en) 1996-01-26
AU3079995A (en) 1996-02-22

Similar Documents

Publication Publication Date Title
CA2493532C (en) Stem cells derived from adipous tissue and differentiated cells derived from said cells
EP0136353B1 (en) Serum-free animal cell culture medium and method for the primary culture and obtention of cell lines using such medium
Bernstam et al. Keratinocytes grown at the air-liquid interface
JP2813467B2 (en) Cell culture methods and media
JP4146802B2 (en) Dedifferentiated programmable stem cells originating from monocytes and their production and use
RU2756584C2 (en) Multipotent stem cells of extrahepatic bile ducts and methods for their isolation
US9801977B2 (en) Method for deriving melanocytes from the hair follicle outer root sheath and preparation for grafting
FR2814752A1 (en) METHOD FOR OBTAINING IN VITRO INSULIN-SECRETORY MAMMAL CELLS AND USES THEREOF
CA2509642A1 (en) Culture medium composition, culture method, and myoblasts obtained, and their uses
FR2792650A1 (en) EQUIVALENT OF ELDERLY SKIN, ITS PREPARATION METHOD AND ITS USE
EP1663263A1 (en) Use of adipose tissue cells for initiating the formation of a functional vascular network
WO2014163206A1 (en) Use of functional melanocytes readily differentiated from multilineage-differentiating stress-enduring (Muse) cells, distinct stem cells in human fibroblasts
US20220213433A1 (en) Three-Dimensional Cross-Linked Scaffolds of Cord Blood Plasma and Their Use
JP6871637B2 (en) Concentration and amplification of highly differentiating human mesenchymal stem cells from the aged cell population
WO1996003496A1 (en) Culture medium promoting endocrine cell growth
Michalak-Micka et al. The influence of CD26+ and CD26− fibroblasts on the regeneration of human dermo-epidermal skin substitutes
FR2962443A1 (en) ADIPOSE TISSUE MODEL AND PROCESS FOR PREPARING THE SAME
WO1993006222A1 (en) Immortalized cerebral endothelial cell lines, process for their preparation and applications thereof as a model for the study of cerebral physiopathology
RU2342164C2 (en) Skin equivalent and method for its production
CA2464196A1 (en) Method for enhancing keratinocyte stem cells
Chen et al. Promotion of β-cell differentiation in pancreatic precursor cells by adult islet cells
JP4669206B2 (en) Methods and compositions for skin grafts
FR2843123A1 (en) Adult, multipotent human stem cells, useful for transplantation for e.g. tissue reconstruction or cosmetic purposes, are isolated from adipose tissue and do not induce rejection
FR3079239A1 (en) NOVEL METHOD OF OBTAINING T CELLS FROM PLURIPOTENT STEM CELLS AND USES THEREOF
CA3070750A1 (en) Functional feline pancreatic cells from adipose tissue

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase